← Leaderboards
Raoul Tibes
Mayo Clinic Arizona
$1,719,179
Attributed
$1,719,179
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $351.7K · FY2013–18$500K$375K$250K$125K$0
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$1,719,179 · 1
By mechanism
R01$1,719,179 · 1
Top collaborators
No co-investigators on record.
Most similar at Mayo Clinic Arizona
Same institution · by research overlap
- Ali Khademhosseini$21,426,218
- Rahmi Oklu$9,676,744
- Fotini Gounari$8,852,868
- Wuqiang Zhu$6,841,350
- Mitesh Borad$4,321,070
Others in their field
Top investigators on “Acute Leukemia”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$158,144,386
- Peter C Adamson · National Childhood Cancer Foundation$144,971,046
- Gregory H Reaman · National Childhood Cancer Foundation$78,926,183
- Todd A Alonzo · University Of Colorado Denver/Hsc Denver$72,436,447
- Brad H. Pollock · University Of Florida$28,825,622
- Timothy J Ley · Washington University$27,865,094
Research focus
Acute LeukemiaAnthracyclinesAtm Signaling PathwayBiological MarkersCancer Therapy Evaluation ProgramCell CycleCell Cycle ArrestCell Cycle CheckpointCellsChek1 GeneCisplatinClinical DataClinical TrialsCombined Modality TherapyCytarabineCytogeneticsCytotoxicCytotoxic AgentDaunorubicinDesignDisease RemissionDna DamageDna RepairDna Repair Gene
Grant awards (5)
CHEK1 and WEE1 Inhibition as Therapeutic Strategies in AML$351,713
R01 · FY2018 · CA · contact PI
CHEK1 and WEE1 Inhibition as Therapeutic Strategies in AML$344,450
R01 · FY2016 · CA · contact PI
CHEK1 and WEE1 Inhibition as Therapeutic Strategies in AML$344,450
R01 · FY2015 · CA · contact PI
CHEK1 and WEE1 Inhibition as Therapeutic Strategies in AML$334,116
R01 · FY2014 · CA · contact PI
CHEK1 and WEE1 Inhibition as Therapeutic Strategies in AML$344,450
R01 · FY2013 · CA · contact PI